185 related articles for article (PubMed ID: 25927437)
1. Deficiency for the cysteine protease cathepsin L impairs Myc-induced tumorigenesis in a mouse model of pancreatic neuroendocrine cancer.
Brindle NR; Joyce JA; Rostker F; Lawlor ER; Swigart-Brown L; Evan G; Hanahan D; Shchors K
PLoS One; 2015; 10(4):e0120348. PubMed ID: 25927437
[TBL] [Abstract][Full Text] [Related]
2. Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis.
Shchors K; Nozawa H; Xu J; Rostker F; Swigart-Brown L; Evan G; Hanahan D
Oncogene; 2013 Jan; 32(4):502-13. PubMed ID: 22391572
[TBL] [Abstract][Full Text] [Related]
3. Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.
Kelly PN; Grabow S; Delbridge AR; Strasser A; Adams JM
Blood; 2011 Dec; 118(24):6380-6. PubMed ID: 21998213
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis.
Gocheva V; Zeng W; Ke D; Klimstra D; Reinheckel T; Peters C; Hanahan D; Joyce JA
Genes Dev; 2006 Mar; 20(5):543-56. PubMed ID: 16481467
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescence.
Bazzar W; Bocci M; Hejll E; Högqvist Tabor V; Hydbring P; Grandien A; Alzrigat M; Larsson LG
Cell Cycle; 2021 Jan; 20(1):23-38. PubMed ID: 33356836
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
7. Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice.
Görgülü K; Diakopoulos KN; Ai J; Schoeps B; Kabacaoglu D; Karpathaki AF; Ciecielski KJ; Kaya-Aksoy E; Ruess DA; Berninger A; Kowalska M; Stevanovic M; Wörmann SM; Wartmann T; Zhao Y; Halangk W; Voronina S; Tepikin A; Schlitter AM; Steiger K; Artati A; Adamski J; Aichler M; Walch A; Jastroch M; Hartleben G; Mantzoros CS; Weichert W; Schmid RM; Herzig S; Krüger A; Sainz B; Lesina M; Algül H
Gastroenterology; 2019 Jan; 156(1):203-217.e20. PubMed ID: 30296435
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis.
Joyce JA; Baruch A; Chehade K; Meyer-Morse N; Giraudo E; Tsai FY; Greenbaum DC; Hager JH; Bogyo M; Hanahan D
Cancer Cell; 2004 May; 5(5):443-53. PubMed ID: 15144952
[TBL] [Abstract][Full Text] [Related]
9. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
10. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins.
Mullins SR; Sameni M; Blum G; Bogyo M; Sloane BF; Moin K
Biol Chem; 2012 Dec; 393(12):1405-16. PubMed ID: 23667900
[TBL] [Abstract][Full Text] [Related]
12. Sensitization to the lysosomal cell death pathway upon immortalization and transformation.
Fehrenbacher N; Gyrd-Hansen M; Poulsen B; Felbor U; Kallunki T; Boes M; Weber E; Leist M; Jäättelä M
Cancer Res; 2004 Aug; 64(15):5301-10. PubMed ID: 15289336
[TBL] [Abstract][Full Text] [Related]
13. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis.
Lawlor ER; Soucek L; Brown-Swigart L; Shchors K; Bialucha CU; Evan GI
Cancer Res; 2006 May; 66(9):4591-601. PubMed ID: 16651409
[TBL] [Abstract][Full Text] [Related]
14. Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.
Cheung WC; Kim JS; Linden M; Peng L; Van Ness B; Polakiewicz RD; Janz S
J Clin Invest; 2004 Jun; 113(12):1763-73. PubMed ID: 15199411
[TBL] [Abstract][Full Text] [Related]
15. c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
Chang TM; Chu PY; Hung WC; Shan YS; Lin HY; Huang KW; Chang JS; Chen LT; Tsai HJ
Cancer Sci; 2021 Jan; 112(1):243-253. PubMed ID: 33128283
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors.
Wang B; Sun J; Kitamoto S; Yang M; Grubb A; Chapman HA; Kalluri R; Shi GP
J Biol Chem; 2006 Mar; 281(9):6020-9. PubMed ID: 16365041
[TBL] [Abstract][Full Text] [Related]
17. Activation-Induced Cytidine Deaminase Contributes to Pancreatic Tumorigenesis by Inducing Tumor-Related Gene Mutations.
Sawai Y; Kodama Y; Shimizu T; Ota Y; Maruno T; Eso Y; Kurita A; Shiokawa M; Tsuji Y; Uza N; Matsumoto Y; Masui T; Uemoto S; Marusawa H; Chiba T
Cancer Res; 2015 Aug; 75(16):3292-301. PubMed ID: 26113087
[TBL] [Abstract][Full Text] [Related]
18. Functional antagonism between pro-apoptotic BIM and anti-apoptotic BCL-XL in MYC-induced lymphomagenesis.
Delbridge AR; Grabow S; Bouillet P; Adams JM; Strasser A
Oncogene; 2015 Apr; 34(14):1872-6. PubMed ID: 24858047
[TBL] [Abstract][Full Text] [Related]
19. MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency.
Moser R; Toyoshima M; Robinson K; Gurley KE; Howie HL; Davison J; Morgan M; Kemp CJ; Grandori C
Mol Cancer Res; 2012 Apr; 10(4):535-45. PubMed ID: 22301954
[TBL] [Abstract][Full Text] [Related]
20. Differential Impact of Cysteine Cathepsins on Genetic Mouse Models of De novo Carcinogenesis: Cathepsin B as Emerging Therapeutic Target.
Reinheckel T; Peters C; Krüger A; Turk B; Vasiljeva O
Front Pharmacol; 2012; 3():133. PubMed ID: 22798952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
